Haselkorn & Thibaut, P.A., operating as Investment Fraud Lawyers has opened a formal investigation into Mark James Derosa (CRD #4180250), a registered representative of Cambridge Investment Research, Inc. and investment adviser representative of Cambridge Investment Research Advisors, Inc.. We are former Wall Street defense attorneys who now leverage our insider knowledge to protect investors nationwide. If you invested with Mark Derosa—especially in Florida, Arizona, or other states where he is active—and have any concerns about your account, we encourage you to review all available information and consider your legal options.
Below is an in-depth investigative report designed to arm you with crucial facts, a clear understanding of any potential red flags, and a path to recover losses if your funds have been mishandled. Our attorneys stand ready to review your case, explain your rights, and discuss possible next steps at no cost. For a confidential consultation, call us directly at 1-888-885-7162.
Background: Who Is Mark James Derosa?
Table of Contents
Mark James Derosa is presently associated with Cambridge Investment Research, Inc. and Cambridge Investment Research Advisors, Inc.. Since entering the industry in 2018, he has obtained multiple securities licenses, including:
- Series 7 – General Securities Representative
- Series 66 – Uniform Combined State Law
- Securities Industry Essentials (SIE)
- Series 6, Series 63, and Series 65 (per public reports)
His registration covers both broker-dealer and registered investment adviser activities. Mark Derosa is authorized to offer securities and investment advice to retail investors through these firms.
Our Regulatory Action Review: The 2026 New York Insurance Matter
Our review as of June 16, 2026, of the BrokerCheck report for Mark Derosa identified one regulatory action disclosure:
| Action Date | Agency | Nature of Regulatory Event | Outcome | Product Category | Penalty |
|---|---|---|---|---|---|
| April 10, 2026 | New York Department of Financial Services | Use of unlicensed agency name, June 2021 through March 2024 | Stipulation and consent, resolved April 21, 2026 | Insurance | $2,000 civil/administrative penalty |
What does this mean for investors? The regulator found that Mark Derosa violated Section 2101(f) of New York Insurance Law by operating under an unlicensed agency name for nearly three years. This is a compliance issue that may matter to investors because clients are entitled to expect transparency and lawful business practices from their financial professionals.
Key Compliance Standards: Why Do These Rules Matter?
- FINRA Rule 2010: Requires registered persons to observe high standards of commercial honor and just and equitable principles of trade. Regulatory actions may raise questions about whether those standards were fully met.
- FINRA Rule 3270: Requires registered individuals to provide prior written notice to their firm regarding outside business activities. Undisclosed or improperly disclosed outside activities can create conflicts of interest or confusion for clients.
- Regulation Best Interest (Reg BI): Imposes a duty on broker-dealers to act in the best interest of retail customers when making recommendations of securities or investment strategies involving securities. Compliance lapses, even outside the securities context, may justify closer scrutiny of overall practices.
Our attorneys have seen how even seemingly limited compliance issues can sometimes point to broader concerns. If an adviser was not fully transparent in one area, investors may wish to review account handling, recommendations, and communications more carefully.
Red Flags and Complaint Review: What Does the Public Record Show?
We conducted a review of publicly available regulatory records, court databases, consumer sources, and media references relating to Mark James Derosa and Cambridge Investment Research, Inc. Based on that review, the following publicly reported items were identified:
- No customer disputes or investor complaints are reported against Mark Derosa on FINRA BrokerCheck.
- No FINRA disciplinary actions appear beyond the insurance-related regulatory disclosure summarized above.
- No public allegations of fraud, misrepresentation, unsuitable recommendations, or theft were identified in readily available federal or state court records reviewed.
- No pending or resolved arbitrations were identified in the reviewed public sources involving Mark Derosa concerning investor losses.
- No adverse SEC or CFTC enforcement action was identified in the reviewed public sources.
- No liens, bankruptcies, or civil financial judgments were identified under Mark Derosa’s name or CRD number in the reviewed public sources.
- No media reports, legal publications, or public complaint sources were identified in the reviewed materials alleging misconduct by Mark Derosa in connection with investment advice.
At this time, aside from the regulatory matter related to the use of an unlicensed agency name, we did not identify a public record of customer complaints, investor arbitration claims, or securities-related misconduct findings against Mark James Derosa in the sources reviewed.
How Our Attorneys Can Help Investors
Regulatory events, even those involving modest penalties, can prompt investors to take a closer look at their accounts, especially if they have noticed unexplained losses, unsuitable recommendations, excessive trading, or communication problems. As former Wall Street defense attorneys, we understand how brokerage firms and advisers respond to investor claims and use that knowledge to advocate for clients seeking recovery.
- Confidential case review: We review account statements, communications, recommendations, and available documentation.
- Attorney-led consultations: Your matter is evaluated by securities attorneys.
- Contingency representation: We charge no fee unless we recover money for you.
- Nationwide representation: We represent investors across the United States in securities arbitration and related matters.
Take Action: Protect Your Investments and Peace of Mind
If you have concerns regarding Mark James Derosa or your accounts with Cambridge Investment Research, Inc., you may wish to seek a legal review of your account activity and the recommendations you received. A prompt review can help determine whether losses were market-driven or whether there may be grounds for a claim.
For a confidential consultation, call 1-888-885-7162.
